These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10976272)

  • 21. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
    Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
    Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
    Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
    In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
    Misawa A; Yasuda M
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
    Siena S; Piccart MJ; Holmes FA; Glaspy J; Hackett J; Renwick JJ
    Oncol Rep; 2003; 10(3):715-24. PubMed ID: 12684649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lithium carbonate on hematopoietic cells in patients with persistent neutropenia following chemotherapy or radiotherapy.
    Hager ED; Dziambor H; Winkler P; Höhmann D; Macholdt K
    J Trace Elem Med Biol; 2002; 16(2):91-7. PubMed ID: 12195731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.
    Cottu PH; Extra JM; Espie M; Marolleau JP; de Roquancourt A; Makke J; Miclea JM; Laurence V; Mayeur D; Lerebours F; Cuvier C; Marty M
    Br J Cancer; 2001 Nov; 85(9):1240-6. PubMed ID: 11720455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A first trial of the use of human recombinant interleukin (rIL-2) in patients with tumorous diseases].
    Grinev MV; Tsibin IuN; Tarelkina MN; Gromov MI; Shirokov DM; Pivovarova LP; Frolov GM; Razumova NK; Masiianskaia TI; Ariskina OB
    Vestn Khir Im I I Grek; 1995; 154(2):57-60. PubMed ID: 8540190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of a multicenter, phase-II clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy].
    Garin AM; Gorbunova VA; Bychkov MB; Mindra NV; Stenina MB; Topchieva SV; Treshchalina EM; Chitiia LV; Sdvizhkov AM; Borisov VI; Gurov SN; Gershanovich ML; Makhnova EV; Nebol'sin VE
    Vopr Onkol; 2004; 50(2):184-8. PubMed ID: 15176221
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leukocyte count and granulocyte function of children under lithium carbonate therapy treated with cytostatic drugs. A pilot study].
    Burdach SE; Rister M; Evers KG; Froehlich W
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):38-42. PubMed ID: 6700601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory reactions during impairment of granulocytic stem in patients with lung cancer receiving antitumor chemotherapy.
    Gol'dberg VE; Zhdanov VV; Matyash MG; Simolina EI; Khrichkova TY; Vysotskaya VV; Popova NO; Boldyshev DA
    Bull Exp Biol Med; 2001 Jun; 131(6):564-7. PubMed ID: 11586408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary report: effects of interleukin-1 on platelet counts.
    Tewari A; Buhles WC; Starnes HF
    Lancet; 1990 Sep; 336(8717):712-4. PubMed ID: 1975894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrinopeptide A in cancer patients and its changes with chemotherapy].
    Ruiz Guinaldo MA; Marugán de la Concha I; Navarro Gonzalo I; García-Conde Bru J
    Sangre (Barc); 1985; 30(6):993-8. PubMed ID: 4095666
    [No Abstract]   [Full Text] [Related]  

  • 37. [Observations on the use of endolymphatic chemotherapy in the palliative treatment of malignant tumors in the advanced stage].
    Porzio R
    Minerva Med; 1968 May; 59(42):2474-8. PubMed ID: 4172473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Iatrogenic disorders of granulocyte function].
    Rister M; Suttorp M
    Beitr Infusionther Klin Ernahr; 1986; 15():268-76. PubMed ID: 3019298
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug treatment principles in malignant tumors of children].
    Gusev LI; Smirtiukov SV; Badolian GKh
    Feldsher Akush; 1983; 48(7):34-7. PubMed ID: 6555092
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant human interleukin-1 beta analogue as a regulator of hematopoiesis in patients receiving chemotherapy for urogenital cancers.
    Iizumi T; Sato S; Iiyama T; Hata R; Amemiya H; Tomomasa H; Yazaki T; Umeda T
    Cancer; 1991 Oct; 68(7):1520-3. PubMed ID: 1893351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.